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DDiscussion
Dr Charles B. Huddleston (St Louis, Mo). This study is re-
markable in a couple of respects. One is that the single-ventricle di-
agnosis was the same for all study groups. Given the heterogeneity
of all patients that end up going through the Fontan pathway, that
has eliminated some of the confounding factors in the analysis by
focusing on this one diagnostic group.
The other interesting aspect, or the remarkable aspect, about this
study is that it took someone, perhaps you, Dr Koh, to go through
the mind-numbing task of reviewing hundreds of electrocardio-
grams measuring these P-wave durations and dispersions because
I do not know that there is an automated way to do that. When I
spoke with our cardiologists about it, I was informed that it could
be done only by hand. Therefore you can imagine the time involved
in that particular task.
I do not think anybody is surprised that there would be this find-
ing about the APC type of Fontan procedure given what we know
about the incidence of atrial arrhythmias after that particular mod-
ification of the Fontan operation.
I think that the other confusing part about this is that the duration
of follow-up plays a major role in the incidence of arrhythmias
found in these patients. No specific arrhythmias were found in
the intracardiac baffle group. There was just this concern based
on the measurements of the P-wave duration and dispersion that
raised further concerns about the possibility of arrhythmia develop-
ment in the future.
Therefore we really are trying to decide as a group, I suppose, or
perhaps individually, whether the intracardiac baffle or the extrac-
ardiac Fontan procedure are the better of the 2 options. I came to
this meeting with my own preconceived notions, listened to the pro-
gram at the postgraduate course yesterday, began to think that
maybe things should be done differently at our center, heard this,
and now I am back to where I was before. Therefore I am not quite
sure where we should be going with all this.
The question that I have for you really is just one about this
study. Specifically, where is the suture line placed for the intracar-
diac baffle? At least in the research we did in our laboratory, that
was a critical aspect of our study, at least in the acute setting, as
to how the atrial conduction was affected by that particular type
of technique. You mentioned that you placed the suture lines for
this baffle on the anterior aspect of the atrium, but could you relateThe Journal of Thoracic and Cathat a little bit to where you make the atriotomy and the linea termi-
nalis of the right atria?
Thank you very much. It was a very good presentation.
Dr Koh. Thank you, Dr Huddleston.
In the IB procedure, first we made an ordinary right atriotomy
from the tip of the appendage toward the inferior vena cava parallel
to the atrioventricular groove. Then we put the looser edge of the
baffle patch along the inferior vena caval orifice and then up to the
line parallel to the atriotomy. Then we connected the tip of the ap-
pendage to the pulmonary artery together with the superior edge
of the patch. Finally, we closed the incision line together with the
other lateral edge of the patch. Therefore in the IB procedure we
have 4 suture lines: one is along the inferior vena caval orifice, 2 par-
allel lines are on the anterior aspect of the right atrial wall, and an-
other line is on the anastomosis site between the appendage and
the pulmonary artery. None of these lines are crossing the terminal
crista. The sinus nodewas placed in the low-pressure atrial chamber.
Dr Carl L. Backer (Chicago, Ill). First, I want to congratulate
you on a great study. In particular, this information is quite useful in
patients who are candidates for a Fontan conversion. The P-wave
analysis, as you previously reported, can be a predictor of when
these patients are going to have atrial arrhythmias and become
a candidate for Fontan conversion operation.
The question I wanted to focus on here was that I noticed that
you had a relatively high incidence of sinus node dysfunction after
the Fontan procedure. I think that if you critically look at patients
who have had any of the Fontan-type procedures, sinus node dys-
function does develop, as happened in your series.
We have been proactive in this area, working in collaboration
with our electrophysiologists. At the time of the primary Fontan
procedure, we now place an epicardial atrial pacing lead, which
we might or might not use in the perioperative period. However,
over a period of time, many of those patients have had sinus
node dysfunction, and we have then gone back and simply put in
a pacemaker generator. You already have the lead, and therefore
you do not have to open up the sternum again.
Given the high incidence of sinus node dysfunction in your se-
ries, what do you think about our strategy of routinely placing a pro-
phylactic atrial epicardial pacing lead at the time of the primary
Fontan procedure?
Dr Koh. We do not use permanent epicardial pacing leads on
a routine basis. None of the patients in our center have had prophy-
lactic pacemaker implantation at the time of the Fontan procedure.
All patients who had sinus node dysfunction in the IB and EC
groups in this series have been asymptomatic and free from atrial
tachyarrhythmia thus far. I am personally reluctant to put a perma-
nent pacing system in asymptomatic patients. I can agree that pac-
ing can suppress atrial tachyarrhythmias, but there is a controversy
about whether pacing is beneficial to the Fontan circulation.rdiovascular Surgery c Volume 140, Number 1 143
